No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Jointown Pharmaceutical Group (600998.SH): Collaborated with Alibaba Cloud, Tencent Cloud, and others in the field of large models.
On February 18, at the interactive platform, Jointown Pharmaceutical Group (600998.SH) stated that 1. Jointown is collaborating with Alibaba Cloud, Tencent Cloud, and others in the area of large models, focusing on applications in the company's intelligent knowledge management, Tongyi Lingma, prescription assistance diagnosis in the treatment system, and AI health education prescriptions. Among these applications regarding the treatment system's large model, AI smart analysis can recommend related symptoms based on the patient's main complaints, suggest indicator references, provide test and examination references, and identify suspected diseases during the prescription process, and after the doctor gives a diagnosis, it can provide recommendations based on the patient's actual conditions.
Jointown Pharmaceutical Group (600998.SH): The company's internal office system has integrated DeepSeek.
On February 13, Gonglonghui reported that Jointown Pharmaceutical Group (600998.SH) stated on the interactive platform that the company's internal office system has integrated with DeepSeek. On one hand, it enhances the company’s office efficiency through intelligent interaction; on the other hand, it utilizes AI deep analysis to extract value from the company's vast business data, providing better insights into the business, optimizing the company's Operation decisions, and enhancing the company's competitiveness. In the future, the company will continue to explore the deep integration of AI technology with its systems, expand more management and Business application scenarios, vigorously promote the efficiency improvement of the company’s pharmaceutical supply chain, Logistics, and other Business areas, and drive the company towards a digital transformation.
Jointown Pharmaceutical Says China Universal Healthcare REIT Raises 1.16 Billion Yuan From Offering
Jointown Pharmaceutical Group (600998.SH): The total amount of funds raised by Huifa Tianfu Jointown Pharmaceutical REIT is 1.158 billion yuan.
Jointown Pharmaceutical Group (600998.SH) announced that on February 12, 2025, Huitianfu Jointown Pharmaceutical Storage...
Individual Investors Own 29% of Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Shares but Private Companies Control 46% of the Company
Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Shares Lagging The Market But So Is The Business
